Over 15 million epilepsy patients worldwide have medically refractory epilepsy (MRE), i.e., they do not respond to anti-epileptic drugs. Successful surgery is a hopeful alternative for seizure freedom but can only be achieved through complete resection or disconnection of the epileptogenic zone (EZ), the brain region(s) where seizures originate. Unfortunately, surgical success rates vary between 30%-70% because no clinically validated biological markers of the EZ exist. Localizing the EZ has thus become a costly and time-consuming process during which a team of clinicians obtain non-invasive neuroimaging data, which is often followed by invasive monitoring involving days-to-weeks of EEG recordings captured intracranially (iEEG). Clinicians visually inspect iEEG data, looking for abnormal activity (e.g., low-voltage high frequency activity) on individual channels occurring immediately before seizures. They also look for abnormal spikes that occur on iEEG between seizures ("resting-state"). In the end, clinicians use <1% of the iEEG data captured to assist in EZ localization (minutes of seizure data versus days of recordings), missing opportunities to leverage these largely ignored data to better diagnose and treat patients. Intracranial EEG offers a unique opportunity to observe rich epileptic cortical network dynamics but waiting for seizures to occur increases patient risks associated invasive monitoring. In this study, we aim to leverage iEEG data in between seizures by developing a new networked-based resting-state iEEG marker of the EZ. We hypothesize that when a patient is not seizing, it is because the EZ is inhibited by neighboring nodes. We develop an algorithm that identifies two groups of nodes from the resting-state iEEG network: those that are continuously inhibiting a set of neighboring nodes ("sources") and the inhibited nodes themselves ("sinks"). Specifically, patient-specific dynamical network models (DNMs) are estimated from minutes of iEEG and their connectivity properties reveal top sources and sinks in the network, with each node being quantified by a source-sink index (SSI). We validate the SSI index in a retrospective analysis of 65 patients by using the SSI of the annotated EZ as a metric to predict surgical outcomes. SSI predicts with an accuracy of 79%, compared to the accuracy of clinicians being 43% (successful outcomes). In failed outcomes, we identify regions of the brain with high SSIs that were untreated. When compared to high frequency oscillations, the most common resting-state iEEG feature proposed for EZ localization, SSI outperformed in predictive power (by a factor of 1.2) suggesting SSI as a resting-state EEG fingerprint of the EZ.